Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 210

1.

Prediction of Arteriovenous Fistula Clinical Maturation from Postoperative Ultrasound Measurements: Findings from the Hemodialysis Fistula Maturation Study.

Robbin ML, Greene T, Allon M, Dember LM, Imrey PB, Cheung AK, Himmelfarb J, Huber TS, Kaufman JS, Radeva MK, Roy-Chaudhury P, Shiu YT, Vazquez MA, Umphrey HR, Alexander L, Abts C, Beck GJ, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2018 Oct 11. pii: ASN.2017111225. doi: 10.1681/ASN.2017111225. [Epub ahead of print]

PMID:
30309898
2.

Postoperative Ultrasound, Unassisted Maturation, and Subsequent Primary Patency of Arteriovenous Fistulas.

Farrington CA, Robbin ML, Lee T, Barker-Finkel J, Allon M.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1364-1372. doi: 10.2215/CJN.02230218. Epub 2018 Aug 23.

PMID:
30139806
3.

Association of Preexisting Arterial Intimal Hyperplasia with Arteriovenous Fistula Outcomes.

Allon M, Litovsky SH, Zhang Y, Le H, Cheung AK, Shiu YT.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1358-1363. doi: 10.2215/CJN.13431217. Epub 2018 Aug 23.

PMID:
30139803
4.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

PMID:
30071516
5.

Choice of a second vascular access in hemodialysis patients whose initial arteriovenous fistula failed to mature.

Al-Balas A, Lee T, Young CJ, Allon M.

J Vasc Surg. 2018 Jun 21. pii: S0741-5214(18)30912-1. doi: 10.1016/j.jvs.2018.03.419. [Epub ahead of print]

PMID:
29937290
6.

Tradeoffs in Vascular Access Selection in Elderly Patients Initiating Hemodialysis With a Catheter.

Lee T, Qian J, Thamer M, Allon M.

Am J Kidney Dis. 2018 Oct;72(4):509-518. doi: 10.1053/j.ajkd.2018.03.023. Epub 2018 May 18.

PMID:
29784614
7.

Abnormalities of vascular histology and collagen fiber configuration in patients with advanced chronic kidney disease.

Allon M, Litovsky SH, Tey JCS, Sundberg CA, Zhang Y, Chen Z, Fang Y, Cheung AK, Shiu YT.

J Vasc Access. 2018 May 1:1129729818773305. doi: 10.1177/1129729818773305. [Epub ahead of print]

PMID:
29742957
8.

Lessons From International Differences in Vascular Access Practices and Outcomes.

Allon M.

Am J Kidney Dis. 2018 Apr;71(4):452-454. doi: 10.1053/j.ajkd.2017.12.004. No abstract available.

PMID:
29579416
9.

Clinical Trial End Points for Hemodialysis Vascular Access: Background, Rationale, and Definitions.

Shenoy S, Allon M, Beathard G, Brouwer-Maier D, Dember LM, Glickman M, Lee C, Litchfield T, Lok C, Huber T, Roy-Chaudhury P, Work J, West M, Wasse H.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):490-494. doi: 10.2215/CJN.13321216. Epub 2018 Feb 27. No abstract available.

PMID:
29487092
10.

Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.

Allon M, Imrey PB, Cheung AK, Radeva M, Alpers CE, Beck GJ, Dember LM, Farber A, Greene T, Himmelfarb J, Huber TS, Kaufman JS, Kusek JW, Roy-Chaudhury P, Robbin ML, Vazquez MA, Feldman HI; Hemodialysis Fistula Maturation (HFM) Study Group.

Am J Kidney Dis. 2018 May;71(5):677-689. doi: 10.1053/j.ajkd.2017.10.027. Epub 2018 Feb 2.

PMID:
29398178
11.

Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas.

Martinez L, Duque JC, Tabbara M, Paez A, Selman G, Hernandez DR, Sundberg CA, Tey JCS, Shiu YT, Cheung AK, Allon M, Velazquez OC, Salman LH, Vazquez-Padron RI.

J Am Soc Nephrol. 2018 Mar;29(3):1030-1040. doi: 10.1681/ASN.2017050559. Epub 2018 Jan 2.

PMID:
29295872
12.

Comparison of postoperative ultrasound criteria to predict unassisted use of arteriovenous fistulas for hemodialysis.

Lee T, Magill M, Burke SK, Blair AT, Robbin ML, Allon M.

J Vasc Access. 2018 Mar;19(2):167-171. doi: 10.5301/jva.5000818. Epub 2018 Feb 19.

PMID:
29283177
13.

Challenges in Developing New Therapies for Vascular Access Dysfunction.

Nath KA, Allon M.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2053-2055. doi: 10.2215/CJN.06650617. Epub 2017 Sep 11. No abstract available.

PMID:
28893922
14.

Vascular Access Type and Clinical Outcomes among Elderly Patients on Hemodialysis.

Lee T, Thamer M, Zhang Q, Zhang Y, Allon M.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1823-1830. doi: 10.2215/CJN.01410217. Epub 2017 Aug 10.

PMID:
28798220
15.

Recommended Clinical Trial End Points for Dialysis Catheters.

Allon M, Brouwer-Maier DJ, Abreo K, Baskin KM, Bregel K, Chand DH, Easom AM, Mermel L, Mokrzycki MH, Patel PR, Roy-Chaudhury P, Shenoy S, Valentini RP, Wasse H.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):495-500. doi: 10.2215/CJN.12011116. Epub 2017 Jul 20.

PMID:
28729382
16.

Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.

Alpers CE, Imrey PB, Hudkins KL, Wietecha TA, Radeva M, Allon M, Cheung AK, Dember LM, Roy-Chaudhury P, Shiu YT, Terry CM, Farber A, Beck GJ, Feldman HI, Kusek JW, Himmelfarb J; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2017 Oct;28(10):3076-3088. doi: 10.1681/ASN.2016050598. Epub 2017 Jul 19.

17.

Intimal Hyperplasia, Stenosis, and Arteriovenous Fistula Maturation Failure in the Hemodialysis Fistula Maturation Study.

Cheung AK, Imrey PB, Alpers CE, Robbin ML, Radeva M, Larive B, Shiu YT, Allon M, Dember LM, Greene T, Himmelfarb J, Roy-Chaudhury P, Terry CM, Vazquez MA, Kusek JW, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2017 Oct;28(10):3005-3013. doi: 10.1681/ASN.2016121355. Epub 2017 Jul 14.

18.

The Clinical and Economic Effect of Vascular Access Selection in Patients Initiating Hemodialysis with a Catheter.

Al-Balas A, Lee T, Young CJ, Kepes JA, Barker-Finkel J, Allon M.

J Am Soc Nephrol. 2017 Dec;28(12):3679-3687. doi: 10.1681/ASN.2016060707. Epub 2017 Jul 14.

PMID:
28710090
19.

Reassessing Recommendations for Choice of Vascular Access.

Lee T, Allon M.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):865-867. doi: 10.2215/CJN.04070417. Epub 2017 May 18. No abstract available.

20.

Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure.

Woo K, Ulloa J, Allon M, Carsten CG 3rd, Chemla ES, Henry ML, Huber TS, Lawson JH, Lok CE, Peden EK, Scher L, Sidawy A, Maggard-Gibbons M, Cull D.

J Vasc Surg. 2017 Apr;65(4):1089-1103.e1. doi: 10.1016/j.jvs.2016.10.099. Epub 2017 Feb 17. Review.

21.

Arteriovenous Grafts: Much Maligned But in Need of Reconsideration?

Allon M.

Semin Dial. 2017 Mar;30(2):125-133. doi: 10.1111/sdi.12567. Epub 2017 Jan 8. Review.

22.

Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Saha M, Allon M.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):357-369. doi: 10.2215/CJN.05260516. Epub 2016 Nov 9. Review.

23.

Central Venous Occlusion in the Hemodialysis Patient.

Krishna VN, Eason JB, Allon M.

Am J Kidney Dis. 2016 Nov;68(5):803-807. doi: 10.1053/j.ajkd.2016.05.017. Epub 2016 Aug 1.

PMID:
27492146
24.

Predictors of Initiation for Predialysis Arteriovenous Fistula.

Al-Balas A, Lee T, Young CJ, Barker-Finkel J, Allon M.

Clin J Am Soc Nephrol. 2016 Oct 7;11(10):1802-1808. doi: 10.2215/CJN.00700116. Epub 2016 Sep 14.

25.

Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula Development.

Shiu YT, Litovsky SH, Cheung AK, Pike DB, Tey JC, Zhang Y, Young CJ, Robbin M, Hoyt K, Allon M.

Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1615-23. doi: 10.2215/CJN.00500116. Epub 2016 Aug 30.

26.

Association of Peritonitis with Hemodialysis Catheter Dependence after Modality Switch.

Lee T, Thamer M, Zhang Y, Zhang Q, Allon M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1999-2004. Epub 2016 Aug 30.

27.

New Insights into Dialysis Vascular Access: Introduction.

Allon M.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1484-6. doi: 10.2215/CJN.01610216. No abstract available.

28.

New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Vazquez-Padron RI, Allon M.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1495-503. doi: 10.2215/CJN.01860216. Epub 2016 Jul 11. Review.

29.

Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.

Lee T, Thamer M, Zhang Q, Zhang Y, Allon M.

Am J Nephrol. 2016;43(5):334-40. doi: 10.1159/000446159. Epub 2016 May 11.

30.

Association between Preoperative Vascular Function and Postoperative Arteriovenous Fistula Development.

Allon M, Greene T, Dember LM, Vita JA, Cheung AK, Hamburg NM, Imrey PB, Kaufman JS, Robbin ML, Shiu YT, Terry CM, Umphrey HR, Feldman HI; Hemodialysis Fistula Maturation Study Group.

J Am Soc Nephrol. 2016 Dec;27(12):3788-3795. Epub 2016 May 9.

31.

We Underutilize the Leg Graft.

Allon M.

Semin Dial. 2016 Jul;29(4):281-3. doi: 10.1111/sdi.12501. Epub 2016 Apr 15.

PMID:
27082708
32.

Outcomes of arteriovenous fistulas and grafts with or without intervention before successful use.

Harms JC, Rangarajan S, Young CJ, Barker-Finkel J, Allon M.

J Vasc Surg. 2016 Jul;64(1):155-62. doi: 10.1016/j.jvs.2016.02.033. Epub 2016 Apr 8.

33.

Arteriovenous Fistula Development in the First 6 Weeks after Creation.

Robbin ML, Greene T, Cheung AK, Allon M, Berceli SA, Kaufman JS, Allen M, Imrey PB, Radeva MK, Shiu YT, Umphrey HR, Young CJ; Hemodialysis Fistula Maturation Study Group.

Radiology. 2016 May;279(2):620-9. doi: 10.1148/radiol.2015150385. Epub 2015 Dec 22.

34.

Treatment of brain oligometastases with hypofractionated stereotactic radiotherapy utilising volumetric modulated arc therapy.

Croker J, Chua B, Bernard A, Allon M, Foote M.

Clin Exp Metastasis. 2016 Feb;33(2):125-32. doi: 10.1007/s10585-015-9762-x. Epub 2015 Oct 19.

PMID:
26482476
35.

Risk Evaluation of Immediate Surgical Failure During Thigh Hemodialysis Graft Placement by Sonographic Screening.

Little MD, Allon M, McNamara MM, Ong S, Lockhart ME, Young CJ, Robbin ML.

J Ultrasound Med. 2015 Sep;34(9):1613-9. doi: 10.7863/ultra.15.14.10002. Epub 2015 Aug 12.

PMID:
26269300
36.

Dialysis: Reducing central venous catheter use in haemodialysis.

Allon M.

Nat Rev Nephrol. 2015 Jun;11(6):323-5. doi: 10.1038/nrneph.2015.56. Epub 2015 Apr 21. No abstract available.

PMID:
25898354
37.

A Patient with Recurrent Arteriovenous Graft Thrombosis.

Allon M.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2255-62. doi: 10.2215/CJN.00190115. Epub 2015 Apr 16.

38.

Outcomes of Elderly Patients after Predialysis Vascular Access Creation.

Lee T, Thamer M, Zhang Y, Zhang Q, Allon M.

J Am Soc Nephrol. 2015 Dec;26(12):3133-40. doi: 10.1681/ASN.2014090938. Epub 2015 Apr 8.

39.

Optical coherence tomography of dialysis graft after angioplasty.

Shingarev R, Allon M.

J Vasc Interv Radiol. 2015 Jun;26(6):870. doi: 10.1016/j.jvir.2015.02.002. Epub 2015 Mar 29. No abstract available.

PMID:
25824318
40.

Preoperative arterial microcalcification and clinical outcomes of arteriovenous fistulas for hemodialysis.

Allon M, Robbin ML, Umphrey HR, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Barker-Finkel J, Litovsky S.

Am J Kidney Dis. 2015 Jul;66(1):84-90. doi: 10.1053/j.ajkd.2014.12.015. Epub 2015 Feb 18.

41.

What is the significance of Staphylococcus aureus colonization in hemodialysis patients?

Narasimha Krishna V, Allon M.

Nephron. 2015;129(2):75-8. doi: 10.1159/000375325. Epub 2015 Feb 13. No abstract available.

42.

Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.

Limdi NA, Nolin TD, Booth SL, Centi A, Marques MB, Crowley MR, Allon M, Beasley TM.

Am J Kidney Dis. 2015 May;65(5):701-9. doi: 10.1053/j.ajkd.2014.11.004. Epub 2014 Nov 25.

43.

Novel paradigms for dialysis vascular access: Introduction.

Allon M.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2183-5. doi: 10.2215/CJN.03650413. No abstract available.

44.

The demented patient who declines to be dialyzed and the unhappy armed police officer son: what should be done?

Allon M, Harbert G, Bova-Collis R, Roberts SV, Moss AH.

Clin J Am Soc Nephrol. 2014 Apr;9(4):804-8. doi: 10.2215/CJN.08400813. Epub 2013 Nov 14.

45.

The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Feng W, Chumley P, Allon M, George J, Scott DW, Patel RP, Litovsky S, Jaimes EA.

J Am Soc Nephrol. 2014 Mar;25(3):475-87. doi: 10.1681/ASN.2013040424. Epub 2013 Nov 7.

46.

Evidence-based cardiology in hemodialysis patients.

Allon M.

J Am Soc Nephrol. 2013 Dec;24(12):1934-43. doi: 10.1681/ASN.2013060632. Epub 2013 Oct 17. Review.

47.

Pneumonia in hemodialysis patients: a challenging diagnosis in the emergency room.

Judd E, Ahmed MI, Harms JC, Terry NL, Sonavane SK, Allon M.

J Nephrol. 2013 Nov-Dec;26(6):1128-35. doi: 10.5301/jn.5000296. Epub 2013 Aug 7.

48.

Natural history of tunneled dialysis catheters placed for hemodialysis initiation.

Shingarev R, Barker-Finkel J, Allon M.

J Vasc Interv Radiol. 2013 Sep;24(9):1289-94. doi: 10.1016/j.jvir.2013.05.034. Epub 2013 Jul 18.

49.

Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.

Allon M, Robbin ML, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Litovsky S.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1750-5. doi: 10.2215/CJN.02740313. Epub 2013 Jun 27.

50.

Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients.

Allon M, Litovsky S, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Robbin ML.

Am J Kidney Dis. 2013 Dec;62(6):1122-9. doi: 10.1053/j.ajkd.2013.03.040. Epub 2013 Jun 5.

Supplemental Content

Support Center